Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002023869-24-000001
Filing Date
2024-06-25
Accepted
2024-06-25 14:30:40
Documents
1
Period of Report
2024-01-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 4284
  Complete submission text file 0002023869-24-000001.txt   5916
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Issuer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 13037 NE BEL RED ROAD SUITE 150 BELLEVUE WA 98005
Business Address 13037 NE BEL RED ROAD SUITE 150 BELLEVUE WA 98005 425-455-2291
LI LENDING, LLC (Reporting) CIK: 0002023869 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-56075 | Film No.: 241068027